Evidence map›Paper›PMID 32507768›Full record

ArticleAging2020

CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD

Yoshio Ogura, Munehiro Kitada, Jing Xu, Itaru Monno, Daisuke Koya

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Food science & nutrition · 2026
    Review
  12. Review
  13. Review
  14. Dysregulation of Niacin-Derived NADMedicina (Kaunas, Lithuania) · 2025
    Article
  15. The Role of Sirt3 in Kidney Health and Disease.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  16. Review
  17. Article
  18. The role of NADnpj metabolic health and disease · 2025
    Review
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yoshio OguraDepartment of Diabetology and Endocrinology, Kanazawa Medical University, Ishikawa, Japan.
Munehiro KitadaDepartment of Diabetology and Endocrinology, Kanazawa Medical University, Ishikawa, Japan.
Jing XuDepartment of Diabetology and Endocrinology, Kanazawa Medical University, Ishikawa, Japan.
Itaru MonnoDepartment of Diabetology and Endocrinology, Kanazawa Medical University, Ishikawa, Japan.
Daisuke KoyaDepartment of Diabetology and Endocrinology, Kanazawa Medical University, Ishikawa, Japan.
Kanazawa Medical University · JPGuiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial oxidative stress is a significant contributor to the pathogenesis of diabetic kidney disease (DKD). We previously showed that mitochondrial oxidative stress in the kidneys of Zucker diabetic fatty rats is associated with a decreased intracellular NAD

Indexed as

ADP-ribosyl CyclaseADP-ribosyl Cyclase 1AnimalsApigeninBlood GlucoseCell LineDiabetes Mellitus, Type 2Diabetic NephropathiesDisease Models, AnimalEpithelial CellsGene Knockdown TechniquesHumansKidney Tubules, ProximalMaleMembrane GlycoproteinsMitochondriaADP-ribosyl CyclaseADP-ribosyl Cyclase 1ApigeninBlood GlucoseCD38 protein, humanCd38 protein, ratMembrane GlycoproteinsNADSIRT3 protein, humanSIRT3 protein, ratSirtuin 3SirtuinsCD38diabetic kidney diseasemitochondrial oxidative stressSirt3

Identifiers

PMID32507768
PMCPMC7343471
OpenAlexW3034018227

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.